UCB Ventures
Overview
UCB Ventures is the strategic corporate venture fund of UCB Pharma. Our mission is to further strengthen UCB's ability to create value from novel insights and technologies that can transform the lives…
Investment Focus
- Innovative therapeutics
- Technology platforms
- Early-stage companies
- High-risk, high-reward science
- Breakthrough innovations in life sciences
Portfolio Companies
Reach UCB Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about UCB Ventures
What sectors does UCB Ventures invest in?
UCB Ventures invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Belgium. UCB Ventures is listed as a corporate vc in the ConnectSafely investor database.
What stage does UCB Ventures invest at?
UCB Ventures backs companies at Pre-Seed, Seed, Series A and Series B, writing cheques of 100K - 1.5M.
Which regions does UCB Ventures invest in?
UCB Ventures invests across United States, United Kingdom, Germany, France, Italy and Denmark.
What companies has UCB Ventures invested in?
UCB Ventures's portfolio includes EsoBiotec, Splice Bio, MyHealthTeams and Syndesi Therapeutics.
How do I contact UCB Ventures?
UCB Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
